WORLD DIAGNOSTICS INC
NT 10-Q, 2000-02-15
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: HOUSEHOLD AUTO RECEIVABLES CORP, 424B3, 2000-02-15
Next: WORLD DIAGNOSTICS INC, 10QSB, 2000-02-15




                     U.S. SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                                  (CHECK ONE):

      [ ] Form 10-K and Form 10-KSB      [ ] Form 20-F      [ ] Form 11-K
      [X] Form 10-Q and Form 10-QSB      [ ] Form N-SAR

For Period Ended:

[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR

For the Transition Period Ended:

- - --------------------------------------------------------------------------------
           Nothing in this Form shall be construed to imply that the
           Commission has verified any information contained herein.
- - --------------------------------------------------------------------------------
         If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:

- - --------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
- - --------------------------------------------------------------------------------

- - --------------------------------------------------------------------------------
Full Name of Registrant (Former Name if Applicable)

WORLD DIAGNOSTICS, INC.
- - --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

15271 N.W. 60th Avenue, Suite #201
- - --------------------------------------------------------------------------------
City, State and Zip Code

Miami Lakes, Florida 33014
- - --------------------------------------------------------------------------------

<PAGE>

PART II - RULES 12b-25(b) AND (c)
- - --------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

[ ] (a)   The reasons described in reasonable detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;

[X] (b)   The subject annual report, semi-annual report, transition report on
          Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion thereof will
          be filed on or before the fifteenth calendar day following the
          prescribed due date; or the subject quarterly report or transition
          report on Form 10-Q, or portion thereof will be filed on or before the
          fifth calendar day following the prescribed due date; and

[ ] (c)   The accountant's statement or other exhibit required by Rule 12b-25(c)
          has been attached if applicable.


<PAGE>

- - --------------------------------------------------------------------------------
PART III - NARRATIVE
- - --------------------------------------------------------------------------------
Certain portions of the unaudited financial statements were produced on disk
that could not be accessed by the filing agent. The problem has been corrected
and the filing will promptly be completed.

- - --------------------------------------------------------------------------------
PART IV - OTHER INFORMATION
- - --------------------------------------------------------------------------------
      (1) Name and telephone number of person to contact in regard to this
notification


   Ken M. Peters, President                 (305)                 827-3304
- - --------------------------------         -----------         ------------------
             (Name)                      (Area Code)         (Telephone Number)

      (2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).

                              [X] Yes     [ ] No

      (3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

<PAGE>

                              [X] Yes     [ ] No

      If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.

      The net loss for the nine months ended December 31, 1999 increased to
$1,153,617 or $(.27) per share from $162,665 or $(.06) per share compared to the
nine months ended December 31, 1998. For the nine months ended December 31,
1999, $585,984 of the loss was attributed to non-cash charges associated with
equity transactions. The loss from operations for the nine months ended
December 31, 1999 was $659,679 or $(.16) per share, an increase of $497,014 over
the nine months ended December 1998. The loss increased primarily due to higher
operating expenses related to staff increases to support the overall growth of
the Company, new computer systems and technical training, continuing website
design, expenses relating to qualifying for the FDA Good Manufacturing practices
License and professional fees associated with the Company's 10-SB Registration
Statement.

 ------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

World Diagnostics, Inc. has caused this notification to be signed on its behalf
by the undersigned thereunto duly authorized.

Date: February 15, 2000                  By: /s/ Ken M. Peters
     -------------------------              -----------------------------------
                                         Name: Ken M. Peters
                                              ---------------------------------
                                         Title: President
                                               --------------------------------



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission